[Presentation of Japanese Materials] Strengthening Research and Development with Industry-Leading Computational Chemistry Tools
[Japanese Flyer] Overview of Computational Chemistry Platform for Life Sciences, Drug Discovery, and Biotechnology
A leading software platform for molecular discovery and optimization for innovators in the biotechnology and pharmaceutical industries. It supports the design of highly efficient new therapeutics through the exploration of vast compound spaces and high-precision predictions of molecular properties. *For more details, please feel free to contact us.*
basic information
For more details, please feel free to contact us.
Price information
For more details, please feel free to contact us.
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
Related Videos
catalog（9）
Download All Catalogs
News about this product（2）
-
From March 27 (Thursday) to March 29 (Saturday), we will exhibit and present at the 145th Annual Meeting of the Pharmaceutical Society of Japan.
Schrödinger, Inc. will exhibit and present at the 145th Annual Meeting of the Pharmaceutical Society of Japan. Formulation research is one of the important processes in drug development, but in recent years, there has been a stronger demand for high efficiency and cost reduction. In this context, recent advancements in computers and molecular simulation technology have made it possible to predict physical properties, which was previously difficult to achieve in practice. In particular, our company is actively engaged in the development of software for formulation research as a leading company in molecular simulation software. 【Joint Symposium Date and Location】 March 27 (Thursday) 17:17 - 17:47 Venue: Room 4 (Fukuoka International Congress Center, 201 [2F]) Title: DX of Formulation Research Using Molecular Simulation and Machine Learning 【Exhibition Booth】 No.: 5F B-22 We look forward to your visit.
-
December 9 (Monday) to December 12 (Thursday) - Participation and presentation at the 3rd Annual Meeting of the Japanese Society for Antibody Research.
Schrödinger, Inc. will participate in the 3rd Annual Meeting of the Japanese Society for Antibody Research. Venue: Sendai International Center (Miyagi) 【Luncheon Seminar】 Date and Time: December 11 (Wed) 12:30 - 13:30 Title: Schrödinger's approach to physics-based antibody analysis and design Presenter: Shuu Ichihara (Schrödinger, Inc.) 【Booth No. 26】 We will introduce Schrödinger's drug discovery support platform and contract analysis services. - Latest docking simulation analysis - High-speed and high-precision binding free energy predictions - Multifunctional ligand-based analysis - Analysis using machine learning - Antibody structure modeling - Protein-protein interaction analysis - Discussion platform for managing, sharing, and analyzing simulation data and experimental data of compounds - Contract analysis services for each simulation
Recommended products
Distributors
Schrödinger Co., Ltd. is the Japanese subsidiary of Schrödinger Inc., headquartered in New York, USA. Schrödinger has a history of about 30 years in developing software that integrates advanced technologies in chemistry and computer science, primarily in the fields of materials science and life sciences, providing advanced solutions for drug discovery, biologics, and materials research and development.